Introduction to CAR T-Cell Therapy and its Impact on Cancer Care
Registration Options
Register for Phone Workshop
Event Date
Thursday, November 05, 2026
1:30 PM - 2:30 PM ET
Presented in Collaboration with:
- Advanced Practitioner Society for Hematology and Oncology (APSHO)
- American Cancer Society
- American Psychosocial Oncology Society
- American Society of Clinical Oncology
- Association for Molecular Pathology
- Association of Clinicians for the Underserved
- Association of Oncology Social Work
- Black Womens Health Imperative
- BMT InfoNet
- Blood Cancer United (formerly Leukemia and Lymphoma Society)
- Bone Marrow and Cancer Foundation
- Cancer Justice
- Cancer Nation
- Cancer Support Community
- Caregiver Action Network
- DKMS We Delete Blood Cancer
- Intercultural Cancer Council
- Joe's House
- Latinas Contra Cancer
- Leukemia Research Foundation
- Lymphoma Foundation of America
- Lymphoma Research Foundation (LRF)
- Multinational Association of Supportive Care in Cancer
- National Association of Social Workers
- National Bone Marrow Transplant Link
- National Comprehensive Cancer Network (NCCN) NCCN Guidelines for Patients
- NeedyMeds
- National LGBT Cancer Network
- NMDPsm
- Prevent Cancer Foundation
- Redes en Acción The National Latino Cancer Research Network
- Research Advocacy Network
- Scott Hamilton CARES Foundation
- The LGBT Cancer Project
- Triage Cancer
- Vital Options International
This activity is supported by Bristol Myers Squibb and Kite Pharma Inc., a subsidiary of Gilead Sciences, Inc. CancerCare’s application for continuing education credits for this program is supported by the Diana Napoli Fund.
Topics Covered
- Overview of CAR T-Cell Therapy
- Understanding CARs – Chimeric Antigen Receptors
- The Benefits of CAR T-Cell Therapy
- When to Consider CAR T-Cell Therapies as a Treatment Choice and Determining Eligibility
- Understanding the CAR T-Cell Therapy Process: From Evaluation to Recovery
- Clinical Trials
- Specific Examples of How CAR T-Cell Therapies Contribute to Oncology Care
- Managing Potential Treatment Side Effects
- Questions for Our Panel of Experts
Speakers
Facilitator
Facilitator
Continuing Education Credits
Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Certified Health Education Specialists (CHES®): This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hour. Cancer Care, Inc is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
To request continuing education paperwork, please fill out the evaluation form(s), included in the email registration packet and evaluation, with your name, address, and license type after the program. For any questions or concerns you may contact us at [email protected]. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program. Forms only open AFTER the live program.